Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
PsychAD studies map molecular mechanisms across major brain disorders

PsychAD studies map molecular mechanisms across major brain disorders

Menopause leaves a blood protein signature linked to brain aging and Alzheimer’s risk

Menopause leaves a blood protein signature linked to brain aging and Alzheimer’s risk

Experimental drug reverses multiple sclerosis damage in mouse model

Experimental drug reverses multiple sclerosis damage in mouse model

New 3D lipid atlas maps the chemistry of mouse brains

New 3D lipid atlas maps the chemistry of mouse brains

People with dementia can participate in research without experiencing significant burden

People with dementia can participate in research without experiencing significant burden

Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101

Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101

New brain circuit discovery offers hope for panic disorder treatments

New brain circuit discovery offers hope for panic disorder treatments

Active form of meprin-β protein increases in people with Alzheimer’s disease

Active form of meprin-β protein increases in people with Alzheimer’s disease

Better fitness was linked to healthier brain structure, but not better memory

Better fitness was linked to healthier brain structure, but not better memory

Sex-specific biological clocks reveal how aging differs across the body in women and men

Sex-specific biological clocks reveal how aging differs across the body in women and men

Social media posts misrepresent Alzheimer's blood test recommendations

Social media posts misrepresent Alzheimer's blood test recommendations

Time-restricted eating may slow early-stage Huntington's disease

Time-restricted eating may slow early-stage Huntington's disease

Salk scientists demonstrate B cells directly enhance killer T cell function

Salk scientists demonstrate B cells directly enhance killer T cell function

New MRI measure maps blood flow and cellular organization

New MRI measure maps blood flow and cellular organization

Reading for pleasure linked to better mental health and greater empathy

Reading for pleasure linked to better mental health and greater empathy

Study explains why Amazonian Indigenous populations show low dementia prevalence

Study explains why Amazonian Indigenous populations show low dementia prevalence

Study links processed foods to targeted domain-specific cognitive decline

Study links processed foods to targeted domain-specific cognitive decline

Eye scans detect signs of atrial fibrillation years before diagnosis

Eye scans detect signs of atrial fibrillation years before diagnosis

APOE genotype helps p-tau217 predict who may develop cognitive impairment sooner

APOE genotype helps p-tau217 predict who may develop cognitive impairment sooner

Brain interference explains why multitasking becomes difficult

Brain interference explains why multitasking becomes difficult

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.